Co-Founder And Ceo
CurrentRostra Therapeutics is a life sciences company set up to develop medicines to treat serious infectious diseases
Please complete the CAPTCHA to continue
@gsk.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
David Findlay is listed as Co-founder and CEO Rostra Therapeutics Ltd at Rostra Therapeutics, based in London, England, United Kingdom. AeroLeads shows a work email signal at gsk.com and a matched LinkedIn profile for David Findlay.
David Findlay previously worked as Co-founder and CEO at Rostra Therapeutics and Lead Consultant at Morton Findlay Associates Limited. David Findlay holds Mba, International Business from Bradford University School Of Management.
This section adds company-level context without repeating David Findlay's masked contact details.
AeroLeads found 2 current-domain work email signals for David Findlay. Compare company email patterns before reaching out.
I am CEO of Rostra Therapeutics Ltd. Set up to develop and commercialise a therapeutic molecular platform out of the University of Strathclyde, Rostra Tx is initially focussing on developing medicines to treat Invasive Fungal Infections.I have a 30+ year career in 'Big Pharma' where I held senior global, regional and local commercial leadership roles in J&J, Glaxo Wellcome, SmithKline Beecham and GSK. I and my teams have focussed on maximising medicine opportunities from early R&D through clinical development, onto launch and through the product lifecycle, delivering niche and blockbuster medicines and accessing patients at a global and local level leading to exceptional revenue growth to maximise ROI. I excel in commercial and portfolio strategy, recruiting, and building teams to deliver exceptional commercial outcomes. I was a co-leader and steering committee member of the DRIVE-AB team, an EFPIA/EU Commission project set up to address the 'broken' antibacterial market through developing new business models. Through my separate consultancy company, Morton Findlay Associates Ltd, I have delivered commercial strategic consultancy services to US and EU pharmaceutical companies, developing market and opportunity assessments, pricing, access and reimbursement strategies and global launch recommendations and plans. My recent therapy area focus has been in the area of anti-infectives to help address the global threat of antimicrobial resistance (AMR). I also have significant experience in many other therapy areas. I present at international conferences and have published on novel business models in leading journals including The Lancet ID, The Journal of Medicine and Ethics, and Philosophical Transactions of the Royal Society
Listed skills include Cross Functional Team Leadership, Pharmaceutical Industry, Strategy, Product Launch, and 16 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
London/Glasgow Uk
Rostra Therapeutics is a life sciences company set up to develop medicines to treat serious infectious diseases
London, United Kingdom
Morton Findlay Associates was set up to deliver global strategic consulting expertise to the pharmaceutical industry. I bring a successful track record to the development of new business models, launch planning in the context of complex multi-national payer environments, market research and forecasting, and delivering aligned, implementable strategies to maximise commercial success. My specialist focus is antibacterials, addressing the commercial challenges of delivering an attractive ROI in this therapy area, but I also work across many therapy areas. I also provide non-executive director services to the healthcare industry. My clients have included GSK, The AMR Centre, Auspherix Pharma, IDEA Pharma, Spero Therapeutics
Gsk House, Brentford, Uk
I was the commercial lead for GSK's global antibacterial and biodefence portfolios (pipeline and in-market), partnering with regions and markets to maximise patient access and ROI.I led R&D/commercial cross-functional teams to develop and implement the global commercial strategy for a portfolio of anti-infective agents in late stage R&D. I was the global commercial lead for business development activities in the antibacterial space, completing many due diligence reviews interfacing directly with potential partner companies. I was the GSK lead on various partnership initiatives to encourage investment to deliver new antibacterials to address antibiotic resistance, including being GSK's lead on the IMI initiative, DRIVE-AB. I have delivered a number of conference presentations recently on the need to incentivise new investment in antibacterial R&D. I have recruited and developed teams to deliver commercial objectives at a global and local level
Gsk House, Brentford, Uk
International Marketing Director for antibiotics and immuno-inflammation covering ex-US markets including Europe, Asia Pacific, Middle East, Africa and Japan.In this role, I developed the GSK antibacterial strategy position for EMEA, Asia-Pacific and Japan through direct liaising with regions and markets, gaining endorsement at President level for the resulting position.I developed competitive reviews of the immuno-inflammation market and pipeline as well as undertaking commercial due diligence on a number of potential in-license medicines. I managed two early stage hospital antibiotics (1 gram-ve, 1 gram +ve), developing target product profiles and associated development plan proposals as the global commercial representative on the Medicine Development Team
London
Centre of Excellence, EU Pharma. Working directly with external stakeholders to determine the opportunity for pandemic medicine stockpiling and developing the strategy for this market segment
Philadelphia, Pa
Based at GSK's antibacterial R&D facility in Philadelphia, I built and managed a team responsible for developing and implementing global disease and asset commercial strategies in a number of anti-infective therapy areas. I was globally responsible for in-market antibacterials, including growing Augmentin sales to £1bn+ and managing the lifecycle through patent expiry. Initially located in US for 3 years, then London due to additional specific EU anti-infective responsibilities.
Harlow, Uk
As part of the Global Strategic Product Development group, I delivered multi-country qualitative and quantitative market research, global forecasts and analytic reports on internal and Business Development assets in anti-infectives and neurosciences.
Welwyn Garden City, Uk
Planned campaigns and interacted directly with external experts to understand unmet need and test medicine propositions as part of pre-launch activities in Alzheimer's and cardiology for UK market launches.
London, United Kingdom
Managing a pilot JV healthcare delivery project in respiratory medicine
Managing a national team of Account Managers with responsibility for maintaining sales of post IP respiratory brands. Targets exceeded.
London, United Kingdom
Marketing manager in NHS Relations team, setting and delivering the communications objectives for the team within the target market of NHS managers. Gathering information on developing NHS structures and drivers and disseminating to internal Glaxo UK teams.
Responsible for 2 sales forces covering all therapy areas - gynaecology, dermatology, analgesia
Launched major Rx analgesic. Managed post launch to become the leading branded analgesic in UK market within one year. Managed gynaecology, dermatology and antifungal portfolios. Launched and terminated products in these therapy areas
Diploma in Marketing (Hammersmith College, 1986)
Quick answers generated from the profile data available on this page.
David Findlay works for Rostra Therapeutics.
David Findlay is listed as Co-founder and CEO Rostra Therapeutics Ltd at Rostra Therapeutics.
AeroLeads has found 2 work email signals at @gsk.com for David Findlay at Rostra Therapeutics.
David Findlay is based in London, England, United Kingdom while working with Rostra Therapeutics.
David Findlay has worked for Rostra Therapeutics, Morton Findlay Associates Limited, Glaxosmithkline, Smithkline Beecham, and Glaxowellcome.
You can use AeroLeads to view verified contact signals for David Findlay at Rostra Therapeutics, including work email, phone, and LinkedIn data when available.
David Findlay holds Mba, International Business from Bradford University School Of Management.
David Findlay is listed with skills including Cross Functional Team Leadership, Pharmaceutical Industry, Strategy, Product Launch, Marketing, Market Research, Global Marketing, and Business Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the David Findlay you were looking for.